skip to main content
Global Search Configuration

New regulatory and drug pricing policies are negatively impacting growth in the Indian pharmaceutical sector, but opportunities remain.


Highlights in this whitepaper include:

  • The effect of tighter regulations on the number of clinical trials conducted in India
  • The impact of inadequate patent protection for branded players and domestic generic manufacturers
  • The challenges faced with compulsory licensing of patented drugs
  • The result the expanding pricing controls will have on the multinational companies
  • Cheap generic medicines vs. branded manufacturers
  • Opportunities and challenges for multinational companies
Indian Pharmaceutical Market

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: